Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adalimumab-induced lupus serositis.

Literature DB >> 25739794

Adalimumab-induced lupus serositis.

Dearbhla Kelly¹, Oisin O'Connell¹, Michael Henry¹.

Abstract

A 61-year-old man presented with a 1-month history of breathlessness, chest pain and lethargy. He had been taking adalimumab for ankylosing spondylitis for 2 years. Pleural and pericardial effusions were both found. A video-assisted thorascopic (VATS) pleural and lung biopsy were performed. The pleural pathology showed eosinophils, acute inflammatory cells and lymphoid aggregates. The patient was positive for antinuclear, antidouble-stranded and antihistone antibodies consistent with drug-induced lupus due to adalimumab. His serositis resolved on withdrawal of the drug. Drug-induced lupus can occur as a consequence of anti-TNF-α agents from induction of autoimmunity in a predisposed host. 2015 BMJ Publishing Group Ltd.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 25739794 PMCID： PMC4368974 DOI： 10.1136/bcr-2014-207323

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

35 in total

1. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

Authors: A W A M van Rijthoven; J W J Bijlsma; M Canninga-van Dijk; R H W M Derksen; J A G van Roon
Journal: Rheumatology (Oxford) Date: 2006-07-13 Impact factor: 7.580

2. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.

Authors: Míriam Mañosa; Eugeni Domènech; Laura Marín; Alejandro Olivé; Yamile Zabana; Eduard Cabré; Miquel A Gassull
Journal: Gut Date: 2008-04 Impact factor: 23.059

3. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors: M C Hochberg
Journal: Arthritis Rheum Date: 1997-09

4. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis.

Authors: B Y Choi; M J Yoon; K Shin; Y J Lee; Y W Song
Journal: Lupus Date: 2014-10-15 Impact factor: 2.911

5. The natural history of ankylosing spondylitis. Does it burn out?

Authors: L G Kennedy; L Edmunds; A Calin
Journal: J Rheumatol Date: 1993-04 Impact factor: 4.666

6. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Authors: P J Charles; R J Smeenk; J De Jong; M Feldmann; R N Maini
Journal: Arthritis Rheum Date: 2000-11

Review 7. Drug-induced lupus: an update.

Authors: S Vasoo
Journal: Lupus Date: 2006 Impact factor: 2.911

Adalimumab-induced lupus serositis.

1. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

2. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.

3. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

4. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis.

5. The natural history of ankylosing spondylitis. Does it burn out?

6. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Review 7. Drug-induced lupus: an update.

8. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

9. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

10. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Review 1. Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases.